Successful thrombolysis using the combination of tissue plasminogen activator and abciximab in an adult with Kawasaki's disease

Journal of Invasive Cardiology

Volumn 13, Issue 9, 2001, Pages 651-653

  Chandwaney, Raj H ^a   Stathopoulos, Tom ^a   Sunew, John ^a   McPherson, David ^a   Davidson, Charles J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Coronary aneurysm; Glycoprotein IIb IIIa inhibitors; Thrombolytics

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY THROMBOSIS; DRUG COMBINATION; FEMALE; HUMAN; MUCOCUTANEOUS LYMPH NODE SYNDROME;

ADULT; ANTIBODIES, MONOCLONAL; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLATELET AGGREGATION INHIBITORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0035458585     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kato H, Koike S, Yamamoto M, et al. Coronary aneurysms in infants and young children with acute febrile MCLNS. J Pediatr 1975;86:892-898.
2. Horigome U, Sekijima T, Miyamoto T. Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki's disease. Heart 1997;78:517-518.
3. Myler RK, Schectmann S, Rosenblum J, et al. Multiple coronary artery ancurysms in an adult associated with extensive thrombus formation resulting in acute myocardial infarction: Successful treatment with intracoronary urokinase, intravenous heparin, and oral anticoagulation. Cathet Cardiovasc Diagn 1991;24:51-54.
4. Tsubata S, Ichida F, Hamamichi Y, et al. Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki's disease. Pediatr Cardiol 1995;16:186-189.
5. Kawasaki T. Febrile occulo-oro-cutaneo-acrodesquamatous syndrome with or without acute non-supportive cervical lymphadenitis in infancy and childhood: Clinical observations of 50 cases. Jpn J Allergy 1967;16:178-222.
6. Bradley DJ, Glode MP. Kawasaki's disease: The mystery continues. West J Med 1998;168:23-29.
7. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki's syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-347.
8. Kato H, Ichinose E, Yoshioka F, et al. Fate of coronary aneurysms in Kawasaki's disease: Serial coronary angiography and long-term follow-up study. Am J Cardiol 1982;49:1758-1766.
9. Syed M, Lesch M. Coronary artery aneurysm: A review. Prog Cardiovasc Dis 1997;40:77-84.
10. Daoud A, Pankin D, Tulgan H, Florentin R. Aneurysms of the coronary artery. Report of ten cases and review of literature. Am J Cardiol 1963;11:228-237.
11. The TIMI 14 Investigators. Abciximab facilitates the rate and extent of thrombolysis: Results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial. Circulation 1999;99:2720-2732.
12. Coller BS. Augmentation of thrombolysis with antiplatelet drugs: Overview. Coron Artery Dis 1996;6:911-914.
13. Cox AD, Devine DV. Factor X. IIb/IIIa binding to activated platelets is mediated through activation of glycoprotein IIb/IIIa. Blood 1994;83:1006-1016.
14. Coller BS. GP IIb/IIIa antagonists: Pathophysiologic and therapeutic insights from studies of c7E3 Fab. Thromb Haemost 1997;78:730-755.